Stockreport

ALZpath and Siemens Healthineers Sign Licensing Agreement to Advance Global Access to Blood-Based Alzheimer's Disease Diagnostic Testing [Yahoo! Finance]

SIEMENS AG SPONS ADR  (SIEGY) 
NASDAQ:AMEX Investor Relations: siemens.com/investor
PDF CARLSBAD, Calif. Dec. 15, 2025 /PRNewswire/ -- ALZpath, Inc. , a leading developer of innovative diagnostic tools for Alzheimer's disease and related dementias, today a [Read more]